サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：院内感染対策の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、エンドユーザー別、地域別
市場調査レポート
商品コード
1398752

院内感染対策の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、エンドユーザー別、地域別

Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 201 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
院内感染対策の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、エンドユーザー別、地域別
出版日: 2023年12月13日
発行: Fairfield Market Research
ページ情報: 英文 201 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の院内感染対策の市場規模は大幅な成長を遂げ、2024年には世界全体の売上が68億米ドルに達し、2031年末には96億米ドルに達すると予測されています。

過去10年間、ヘルスケアを取り巻く環境は、先進医療技術の導入によって著しい変貌を遂げてきました。感染症や慢性疾患の流行が急増する中、消毒・滅菌装置の必要性はかつてないほど高まっています。

一般市民の医療関連感染に対する意識の高まりが、感染対策の必要性を高めています。医療施設における感染管理システムの強化を目的とした政府のプログラムは、市場拡大において極めて重要な役割を果たしています。感染症や伝染病の罹患率が上昇していることが、感染管理技術の需要を促進しています。パンデミックにより医療現場における感染管理の重要性が浮き彫りになり、関連機器の需要増につながっています。

当レポートでは、世界の院内感染対策市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の院内感染対策市場の見通し、2018年～2031年

  • 世界の院内感染対策市場の見通し、製品別、金額（10億米ドル）、数量（100万個）、2018年～2031年
  • 世界の院内感染対策市場の見通し、エンドユーザー別、金額（10億米ドル）、数量（100万個）、2018年～2031年
  • 世界の院内感染対策市場の見通し、地域別、金額（10億米ドル）、数量（100万個）、2018年～2031年

第4章 北米の院内感染対策市場の見通し、2018年～2031年

第5章 欧州の院内感染対策市場の見通し、2018年～2031年

第6章 アジア太平洋の院内感染対策市場の見通し、2018年～2031年

第7章 ラテンアメリカの院内感染対策市場の見通し、2018年～2031年

第8章 中東・アフリカの院内感染対策市場の見通し、2018年～2031年

第9章 競合情勢

  • 製品とエンドユーザーのヒートマップ
  • メーカーとエンドユーザーのヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Olympus Corporation
    • Medivators Inc. (Cantel Medical Corp.)
    • Getinge Group
    • STERIS Plc.
    • Belimed AG (Metall Zug)
    • Steelco S.P.A.
    • Pfizer Inc.,
    • F. Hoffmann-La Roche Ltd,
    • Merck & Co.,
    • Advanced Sterilization Products Services Inc.
    • Abbott Laboratories
    • Bayer AG
    • The 3M Company
    • Cepheid Inc.
    • UVision360 Inc.

第10章 付録

目次

The Hospital Acquired Infection Control Market is poised for substantial growth, with worldwide revenue reaching US$ 6.8 Billion in 2024 and anticipated to propel the market to US$ 9.6 Billion by the end of 2031, according to the latest report by Fairfield Market Research.

Changing Healthcare Infrastructure and the Demand for Infection Control

Over the past decade, the healthcare landscape has undergone significant transformations, marked by the adoption of advanced medical technologies. As the prevalence of infectious and chronic diseases has surged, the need for disinfection and sterilization equipment has never been more critical.

Driving Factors for Hospital Acquired Infection Control Market Expansion

Several factors are contributing to the growing demand for hospital-acquired infection control technology:

  • Rising Public Awareness: Increasing awareness about healthcare-associated infections among the public is driving the need for infection control measures.
  • Government Initiatives: Government programs aimed at strengthening infection control systems in medical facilities are playing a pivotal role in market expansion.
  • Prevalence of Infectious Diseases: The rising incidence of infectious and communicable diseases is fueling the demand for infection control technology.
  • Impact of COVID-19: The pandemic underscored the importance of infection control in healthcare settings, leading to increased demand for related equipment.

Manufacturers Expanding Their Markets

Manufacturers in the hospital acquired infection control market are expanding their reach through various strategies:

  • Increased awareness about personal hygiene is driving the demand for sterilized medical equipment, especially as the number of surgical procedures rises.
  • The demand for nosocomial infection control equipment is growing as people recognize the benefits of sterilization.
  • Minimally invasive procedures and the rise of outpatient services are contributing to market growth.
  • Increasing government initiatives and growing public awareness are expanding the number of outpatients, further driving market progress.

Challenges in Market Progress

While the hospital acquired infection control market holds immense potential, challenges exist:

  • The complexity of infection control methods and the need for advanced technologies can be obstacles.
  • Reprocessing technology for medical devices poses challenges in ensuring their safety for reuse, affecting market expansion to some extent.

Booming Market in the United States

The United States presents a highly lucrative market for hospital-acquired infection control equipment due to its advanced healthcare system, high healthcare costs, and widespread public awareness of infection control issues. It is expected to generate a significant share of the region's revenue.

Emerging Market in China

China is emerging as a prominent market for hospital-acquired infection control, driven by increasing public awareness of hospital-acquired infections, government support programs, and a rising number of such infections. China is expected to dominate in terms of revenue share.

Focus on India

India, as the second-most populous country in the world, offers substantial potential for hospital-acquired infection control equipment suppliers. As hygiene awareness and attention to healthcare intensify, India is likely to experience significant growth in demand for disinfection equipment. The nation's healthcare infrastructure is expected to advance rapidly over the next decade, presenting opportunities for local market players.

Competitive Landscape

The healthcare-associated infections segment has gained significant attention, prompting key industry players to invest in research and development and launch new products. Some key companies profiled in the hospital acquired infection control market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Market Segmentation

By Product :

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
  • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
  • Endoscopic Reprocessor Systems
    • Single Basin Endoscopic Reprocessor Systems
    • Dual Basin Endoscopic Reprocessor Systems
  • Disinfectants

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hospital Acquired Infection Control Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Heat Sterilization Equipment
        • 3.1.1.1.1. Moist Heat Sterilization Equipment
        • 3.1.1.1.2. Dry Heat Sterilization Equipment
      • 3.1.1.2. Low-Temperature Sterilization Equipment
      • 3.1.1.3. Radiation Sterilization Equipment
      • 3.1.1.4. Disinfection Equipment
        • 3.1.1.4.1. Disinfector
          • 3.1.1.4.1.1. Disinfector
            • 3.1.1.4.1.1.1. Washer Disinfector
            • 3.1.1.4.1.1.2. Flusher Disinfector
        • 3.1.1.4.2. Flusher Disinfector
      • 3.1.1.5. Endoscopic Reprocessor Systems
        • 3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 3.1.1.6. Disinfectants
  • 3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical Centres
      • 3.2.1.3. Medical Institutions
      • 3.2.1.4. Diagnostic Laboratories
      • 3.2.1.5. Clinics
  • 3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Heat Sterilization Equipment
        • 4.1.1.1.1. Moist Heat Sterilization Equipment
        • 4.1.1.1.2. Dry Heat Sterilization Equipment
      • 4.1.1.2. Low-Temperature Sterilization Equipment
      • 4.1.1.3. Radiation Sterilization Equipment
      • 4.1.1.4. Disinfection Equipment
        • 4.1.1.4.1. Disinfector
          • 4.1.1.4.1.1. Disinfector
            • 4.1.1.4.1.1.1. Washer Disinfector
            • 4.1.1.4.1.1.2. Flusher Disinfector
        • 4.1.1.4.2. Flusher Disinfector
      • 4.1.1.5. Endoscopic Reprocessor Systems
        • 4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 4.1.1.6. Disinfectants
  • 4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ambulatory Surgical Centres
      • 4.2.1.3. Medical Institutions
      • 4.2.1.4. Diagnostic Laboratories
      • 4.2.1.5. Clinics
  • 4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Heat Sterilization Equipment
        • 5.1.1.1.1. Moist Heat Sterilization Equipment
        • 5.1.1.1.2. Dry Heat Sterilization Equipment
      • 5.1.1.2. Low-Temperature Sterilization Equipment
      • 5.1.1.3. Radiation Sterilization Equipment
      • 5.1.1.4. Disinfection Equipment
        • 5.1.1.4.1. Disinfector
          • 5.1.1.4.1.1. Disinfector
            • 5.1.1.4.1.1.1. Washer Disinfector
            • 5.1.1.4.1.1.2. Flusher Disinfector
        • 5.1.1.4.2. Flusher Disinfector
      • 5.1.1.5. Endoscopic Reprocessor Systems
        • 5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 5.1.1.6. Disinfectants
  • 5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ambulatory Surgical Centres
      • 5.2.1.3. Medical Institutions
      • 5.2.1.4. Diagnostic Laboratories
      • 5.2.1.5. Clinics
  • 5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Heat Sterilization Equipment
        • 6.1.1.1.1. Moist Heat Sterilization Equipment
        • 6.1.1.1.2. Dry Heat Sterilization Equipment
      • 6.1.1.2. Low-Temperature Sterilization Equipment
      • 6.1.1.3. Radiation Sterilization Equipment
      • 6.1.1.4. Disinfection Equipment
        • 6.1.1.4.1. Disinfector
          • 6.1.1.4.1.1. Disinfector
            • 6.1.1.4.1.1.1. Washer Disinfector
            • 6.1.1.4.1.1.2. Flusher Disinfector
        • 6.1.1.4.2. Flusher Disinfector
      • 6.1.1.5. Endoscopic Reprocessor Systems
        • 6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 6.1.1.6. Disinfectants
  • 6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ambulatory Surgical Centres
      • 6.2.1.3. Medical Institutions
      • 6.2.1.4. Diagnostic Laboratories
      • 6.2.1.5. Clinics
  • 6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Heat Sterilization Equipment
        • 7.1.1.1.1. Moist Heat Sterilization Equipment
        • 7.1.1.1.2. Dry Heat Sterilization Equipment
      • 7.1.1.2. Low-Temperature Sterilization Equipment
      • 7.1.1.3. Radiation Sterilization Equipment
      • 7.1.1.4. Disinfection Equipment
        • 7.1.1.4.1. Disinfector
          • 7.1.1.4.1.1. Disinfector
            • 7.1.1.4.1.1.1. Washer Disinfector
            • 7.1.1.4.1.1.2. Flusher Disinfector
        • 7.1.1.4.2. Flusher Disinfector
      • 7.1.1.5. Endoscopic Reprocessor Systems
        • 7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 7.1.1.6. Disinfectants
  • 7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ambulatory Surgical Centres
      • 7.2.1.3. Medical Institutions
      • 7.2.1.4. Diagnostic Laboratories
      • 7.2.1.5. Clinics
  • 7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Heat Sterilization Equipment
        • 8.1.1.1.1. Moist Heat Sterilization Equipment
        • 8.1.1.1.2. Dry Heat Sterilization Equipment
      • 8.1.1.2. Low-Temperature Sterilization Equipment
      • 8.1.1.3. Radiation Sterilization Equipment
      • 8.1.1.4. Disinfection Equipment
        • 8.1.1.4.1. Disinfector
          • 8.1.1.4.1.1. Disinfector
            • 8.1.1.4.1.1.1. Washer Disinfector
            • 8.1.1.4.1.1.2. Flusher Disinfector
        • 8.1.1.4.2. Flusher Disinfector
      • 8.1.1.5. Endoscopic Reprocessor Systems
        • 8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 8.1.1.6. Disinfectants
  • 8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ambulatory Surgical Centres
      • 8.2.1.3. Medical Institutions
      • 8.2.1.4. Diagnostic Laboratories
      • 8.2.1.5. Clinics
  • 8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Olympus Corporation
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Medivators Inc. (Cantel Medical Corp.)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Getinge Group
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. STERIS Plc.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Belimed AG (Metall Zug)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Steelco S.P.A.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Pfizer Inc.,
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. F. Hoffmann-La Roche Ltd,
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Merck & Co.,
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Abbott Laboratories
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bayer AG
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. The 3M Company
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Cepheid Inc.
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. UVision360 Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations